Overview
Vertex Pharmaceuticals Incorporated, based in the United States, operates chiefly within the biotechnology industry, focusing on developing and commercializing therapies for serious diseases. Renowned for its significant advances in cystic fibrosis (CF) treatments, Vertex has successfully brought several groundbreaking medications to market that enhance the quality of life for patients with this genetic disorder. Besides its flagship CF products, the company actively expands its research and development pipeline across various other therapeutic categories including sickle cell disease, beta thalassemia, and pain management. Vertex's strategic initiatives aim to leverage its expertise in small molecule drug development to explore potential treatments in additional diseases with significant unmet medical needs.
Basic Stats
The share price of Vertex Pharmaceuticals Incorporated as of 5 September 2025 is US$397.29 / share. This is an increase of 1.33% from the prior week. The market cap (or net worth) of Vertex Pharmaceuticals Incorporated as of 5 September 2025 is US$101,735.72 MM.
The Factor Analysis chart (below right) shows a view of Vertex Pharmaceuticals Incorporated from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 101,735.72 MM |
| EV | 95,352.92 MM |
| Shares Out. | 256.30 MM |
| Earnings Date | |
| EPS (TTM) | 14.19 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -15.06 % |
| Volatility (1 yr) | 0.35 |
| Beta | 0.41 |
| Sharpe Ratio (1 yr) | -0.55 |
| Sortino Ratio (1 yr) | -0.68 |
| PE Ratio | 27.97 |
| Price/Book | 5.92 |
| Price/TBV | 6.50 |
| Book/Market | 0.17 |
| EBIT/EV | 0.05 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.18 |
| ROE | 0.25 |
| ROIC | 0.19 |
| CROIC | 0.02 |
| OCROIC | 0.21 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 71.66 /100 |
| Profitability | 83.09 /100 |
| Quality Score | 53.62 /100 |
| Value Score | 54.77 /100 |
| Momentum Score | 13.18 /100 |
| Stability (Low Vol) Score | 63.47 /100 |
| Analyst Sentiment | 59.83 /100 |
| Fund Sentiment | 20.48 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 7.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Vertex Pharmaceuticals Incorporated is US$494.67. The forecasts range from a low of US$335.29 to a high of US$659.10. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Vertex Pharmaceuticals Incorporated. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-06-27 | Redburn Atlantic | Buy | Initiate | |
| 2024-06-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-06-17 | Argus Research | Buy | Buy | Maintains |
| 2024-06-11 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-06-04 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-05-31 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-05-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-05-07 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-05-07 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-05-07 | Needham | Hold | Reiterate | |
| 2024-04-18 | Guggenheim | Buy | Buy | Maintains |
| 2024-04-17 | UBS | Buy | Buy | Maintains |
| 2024-04-15 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-12 | Canaccord Genuity | Sell | Sell | Maintains |
| 2024-04-11 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-04-11 | Evercore ISI Group | In-Line | Outperform | Upgrade |
| 2024-02-20 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-15 | Wolfe Research | Outperform | Initiate | |
| 2024-02-06 | Barclays | Overweight | Overweight | Maintains |
| 2024-02-06 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-02-06 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-02-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-02-06 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-02-06 | Evercore ISI Group | Outperform | In-Line | Downgrade |
| 2024-02-06 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-02-02 | Bernstein | Outperform | Market Perform | Downgrade |
| 2024-02-01 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-01-31 | Maxim Group | Buy | Hold | Downgrade |
| 2024-01-31 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-01-31 | Truist Securities | Buy | Buy | Maintains |
| 2024-01-24 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-01-24 | Canaccord Genuity | Hold | Sell | Downgrade |
| 2024-01-12 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-09 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-12-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-11 | Barclays | Overweight | Overweight | Maintains |
| 2023-12-11 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2023-12-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-22 | Stifel | Hold | Hold | Reiterate |
| 2023-11-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-11-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-07 | Stifel | Hold | Hold | Maintains |
| 2023-11-07 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2023-11-07 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-11-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-11-07 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2023-10-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-16 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-09 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-04 | Truist Securities | Buy | Buy | Reiterate |
| 2023-09-29 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-09-07 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-07 | Canaccord Genuity | Hold | Hold | Maintains |
| 2023-08-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-08-02 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-08-02 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-02 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-08-02 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-08-02 | Barclays | Overweight | Overweight | Maintains |
| 2023-08-02 | Bernstein | Outperform | Outperform | Maintains |
| 2023-08-02 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-07-21 | B of A Securities | Buy | Buy | Maintains |
| 2023-07-03 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-06-30 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-06-26 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2023-06-26 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-06-23 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-06-22 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-06-12 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2023-06-08 | RBC Capital | Sector Perform | Maintains | |
| 2023-05-30 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-05-30 | William Blair | Outperform | Initiate | |
| 2023-05-03 | Maxim Group | Buy | Maintains | |
| 2023-05-03 | Bernstein | Outperform | Maintains | |
| 2023-05-02 | RBC Capital | Sector Perform | Maintains | |
| 2023-05-02 | Truist Securities | Buy | Maintains | |
| 2023-05-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-02 | Guggenheim | Buy | Maintains | |
| 2023-05-02 | Stifel | Hold | Maintains | |
| 2023-05-02 | Baird | Neutral | Maintains | |
| 2023-05-02 | Oppenheimer | Outperform | Maintains | |
| 2023-05-02 | HC Wainwright & Co. | Buy | Maintains | |
| 2023-05-02 | Barclays | Overweight | Maintains | |
| 2023-03-29 | Argus Research | Buy | Maintains | |
| 2023-03-21 | Bernstein | Outperform | Initiate | |
| 2023-02-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-08 | Piper Sandler | Neutral | Maintains | |
| 2023-02-08 | Barclays | Overweight | Maintains | |
| 2023-02-08 | HC Wainwright & Co. | Buy | Maintains | |
| 2023-02-08 | SVB Leerink | Outperform | Maintains | |
| 2023-01-24 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-19 | Piper Sandler | Neutral | Maintains | |
| 2023-01-18 | Canaccord Genuity | Hold | Initiate | |
| 2023-01-17 | SVB Leerink | Market Perform | Outperform | Upgrade |
| 2022-12-19 | Jefferies | Buy | Hold | Downgrade |
| 2022-11-17 | Argus Research | Buy | Maintains | |
| 2022-10-28 | RBC Capital | Sector Perform | Maintains | |
| 2022-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-28 | Barclays | Overweight | Maintains | |
| 2022-10-28 | Wells Fargo | Overweight | Maintains | |
| 2022-10-24 | JP Morgan | Overweight | Maintains | |
| 2022-08-17 | Piper Sandler | Neutral | Maintains | |
| 2022-08-08 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-08-05 | HC Wainwright & Co. | Buy | Maintains | |
| 2022-08-05 | Barclays | Overweight | Maintains | |
| 2022-07-26 | Piper Sandler | Neutral | Maintains | |
| 2022-07-13 | Cantor Fitzgerald | Overweight | Initiate | |
| 2022-06-13 | Argus Research | Buy | Maintains | |
| 2022-06-13 | Cowen & Co. | Outperform | Maintains | |
| 2022-06-01 | Maxim Group | Hold | Buy | Upgrade |
| 2022-05-23 | SVB Leerink | Market Perform | Initiate | |
| 2022-05-06 | Piper Sandler | Neutral | Maintains | |
| 2022-05-03 | Morgan Stanley | Underweight | Equal-Weight | Upgrade |
| 2022-04-22 | Piper Sandler | Neutral | Maintains | |
| 2022-04-05 | Wells Fargo | Overweight | Maintains | |
| 2022-02-03 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2022-01-20 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2021-12-09 | Wells Fargo | Overweight | Initiate | |
| 2021-12-02 | RBC Capital | Outperform | Maintains | |
| 2021-11-19 | BMO Capital | Market Perform | Initiate | |
| 2021-11-19 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-11-03 | RBC Capital | Outperform | Maintains | |
| 2021-09-09 | Stifel | Buy | Hold | Downgrade |
| 2021-09-07 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2021-07-30 | Piper Sandler | Overweight | Maintains | |
| 2021-07-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-07-30 | RBC Capital | Outperform | Maintains | |
| 2021-07-30 | SVB Leerink | Underperform | Maintains | |
| 2021-07-20 | SVB Leerink | Market Perform | Underperform | Downgrade |
| 2021-07-01 | Raymond James | Market Perform | Initiate | |
| 2021-06-14 | Piper Sandler | Overweight | Maintains | |
| 2021-06-14 | Truist Securities | Buy | Maintains | |
| 2021-06-14 | SVB Leerink | Market Perform | Maintains | |
| 2021-06-11 | Citigroup | Buy | Maintains | |
| 2021-06-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-06-11 | Baird | Outperform | Maintains | |
| 2021-06-11 | Stifel | Buy | Maintains | |
| 2021-06-11 | Cantor Fitzgerald | Overweight | Maintains | |
| 2021-06-11 | Goldman Sachs | Buy | Maintains | |
| 2021-06-11 | RBC Capital | Outperform | Maintains | |
| 2021-06-11 | Barclays | Overweight | Maintains | |
| 2021-04-30 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-04-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-02-23 | Baird | Neutral | Outperform | Upgrade |
| 2021-02-02 | BMO Capital | Outperform | Maintains | |
| 2021-02-02 | Piper Sandler | Overweight | Maintains | |
| 2021-02-02 | Credit Suisse | Outperform | Maintains | |
| 2021-02-02 | SVB Leerink | Market Perform | Maintains | |
| 2021-01-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-30 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2020-11-20 | Bernstein | Outperform | Initiate | |
| 2020-10-30 | Credit Suisse | Outperform | Maintains | |
| 2020-10-30 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-28 | UBS | Buy | Initiate | |
| 2020-10-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-10-15 | SVB Leerink | Market Perform | Maintains | |
| 2020-10-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-08-24 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-31 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-07-31 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-07-31 | SVB Leerink | Market Perform | Maintains | |
| 2020-07-20 | Credit Suisse | Outperform | Maintains | |
| 2020-07-08 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2020-06-24 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2020-06-12 | Citigroup | Buy | Maintains | |
| 2020-05-15 | Argus Research | Buy | Maintains | |
| 2020-05-01 | Citigroup | Buy | Maintains | |
| 2020-04-30 | BMO Capital | Outperform | Maintains | |
| 2020-04-30 | Guggenheim | Buy | Maintains | |
| 2020-04-30 | CFRA | Buy | Maintains | |
| 2020-04-30 | JMP Securities | Market Outperform | Maintains | |
| 2020-04-30 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-30 | Stifel | Buy | Maintains | |
| 2020-04-30 | Oppenheimer | Outperform | Maintains | |
| 2020-04-30 | SVB Leerink | Market Perform | Maintains | |
| 2020-04-30 | HC Wainwright & Co. | Buy | Maintains | |
| 2020-04-28 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2020-04-15 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-11 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-01-31 | B of A Securities | Buy | Maintains | |
| 2020-01-31 | Morgan Stanley | Overweight | Maintains | |
| 2020-01-31 | CFRA | Buy | Maintains | |
| 2020-01-31 | RBC Capital | Outperform | Maintains | |
| 2020-01-31 | Stifel Nicolaus | Buy | Maintains | |
| 2020-01-31 | Credit Suisse | Outperform | Maintains | |
| 2020-01-31 | Baird | Outperform | Neutral | Downgrade |
| 2020-01-08 | Oppenheimer | Outperform | Maintains | |
| 2020-01-06 | PiperJaffray | Overweight | Maintains | |
| 2019-12-18 | JP Morgan | Overweight | Maintains | |
| 2019-11-20 | Bank of America | Buy | Reiterate | |
| 2019-11-19 | Cantor Fitzgerald | Overweight | Maintains | |
| 2019-11-12 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2019-10-31 | Piper Jaffray | Overweight | Maintains | |
| 2019-10-31 | Stifel Nicolaus | Buy | Maintains | |
| 2019-10-31 | Morgan Stanley | Overweight | Maintains | |
| 2019-10-22 | Citigroup | Buy | Maintains | |
| 2019-09-06 | Morgan Stanley | Overweight | Maintains | |
| 2019-09-03 | Goldman Sachs | Buy | Reiterate | |
| 2019-08-01 | Stifel Nicolaus | Buy | Maintains | |
| 2019-08-01 | Needham | Buy | Hold | Downgrade |
| 2019-08-01 | Credit Suisse | Outperform | Maintains | |
| 2019-08-01 | Piper Jaffray | Overweight | Maintains | |
| 2019-05-21 | Credit Suisse | Outperform | Initiate | |
| 2019-04-12 | Evercore ISI Group | In-Line | Initiate | |
| 2019-03-26 | William Blair | Market Perform | Outperform | Upgrade |
| 2019-03-19 | SVB Leerink | Outperform | Market Perform | Downgrade |
| 2019-03-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2019-01-04 | Citigroup | Buy | Buy | Maintains |
| 2019-01-02 | Raymond James | Market Outperform | Market Perform | Downgrade |
| 2018-12-19 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-10-26 | H.C. Wainwright | Neutral | Buy | Upgrade |
| 2018-10-25 | Raymond James | Outperform | Outperform | Maintains |
| 2018-10-25 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-10-01 | Cantor Fitzgerald | Overweight | Initiate | |
| 2018-07-30 | Citigroup | Buy | Buy | Maintains |
| 2018-07-26 | UBS | Neutral | Neutral | Maintains |
| 2018-07-26 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-04-27 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-03-05 | Maxim Group | Buy | Buy | Maintains |
| 2018-02-13 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-02-13 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-02-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-02-01 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-02-01 | Bank of America | Buy | Buy | Maintains |
| 2018-02-01 | Barclays | Overweight | Overweight | Maintains |
| 2018-01-05 | Bank of America | Neutral | Buy | Upgrade |
| 2017-12-13 | Deutsche Bank | Buy | Initiate | |
| 2017-09-29 | DA Davidson | Buy | Initiate | |
| 2017-09-15 | RBC Capital | Outperform | Initiate | |
| 2017-07-19 | Citigroup | Buy | Maintains | |
| 2017-07-19 | Raymond James | Market Perform | Outperform | Upgrade |
| 2017-07-19 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2017-07-19 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2017-07-19 | Janney Capital | Neutral | Buy | Upgrade |
| 2017-07-11 | Jefferies | Buy | Initiate | |
| 2017-06-23 | Needham | Hold | Buy | Upgrade |
| 2017-06-02 | Oppenheimer | Perform | Outperform | Upgrade |
| 2017-03-29 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2017-03-17 | JMP Securities | Market Perform | Market Outperform | Upgrade |
| 2016-12-15 | Oppenheimer | Perform | Initiate | |
| 2016-11-29 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2016-11-18 | Janney Capital | Neutral | Initiate | |
| 2016-11-01 | William Blair | Outperform | Market Perform | Downgrade |
| 2016-10-24 | H.C. Wainwright | Buy | Neutral | Downgrade |
| 2016-10-05 | Jefferies | Buy | Maintains | |
| 2016-09-29 | Jefferies | Buy | Maintains | |
| 2016-09-13 | Raymond James | Market Perform | Initiate | |
| 2016-07-28 | Morgan Stanley | Overweight | Maintains | |
| 2016-04-28 | Goldman Sachs | Buy | Neutral | Downgrade |
| 2016-04-11 | Credit Suisse | Outperform | Maintains | |
| 2016-04-07 | BMO Capital | Market Perform | Initiate | |
| 2016-03-08 | Leerink Swann | Outperform | Maintains | |
| 2016-02-05 | Leerink Swann | Outperform | Initiate | |
| 2016-02-01 | Jefferies | Hold | Buy | Upgrade |
| 2016-01-29 | Barclays | Overweight | Maintains | |
| 2016-01-28 | Barclays | Overweight | Maintains | |
| 2016-01-28 | JP Morgan | Overweight | Maintains | |
| 2016-01-20 | Credit Suisse | Outperform | Initiate | |
| 2015-12-01 | Stifel Nicolaus | Buy | Initiate | |
| 2015-10-30 | H.C. Wainwright | Neutral | Buy | Upgrade |
| 2015-10-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2015-09-28 | Argus | Hold | Buy | Upgrade |
| 2015-09-14 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2015-09-09 | Jefferies | Hold | Initiate | |
| 2015-07-30 | JMP Securities | Market Outperform | Maintains | |
| 2015-07-06 | Bank of America | Neutral | Maintains | |
| 2015-07-06 | Leerink Swann | Outperform | Maintains | |
| 2015-06-23 | RBC Capital | Outperform | Maintains | |
| 2015-04-30 | Citigroup | Buy | Maintains | |
| 2015-04-10 | Canaccord Genuity | Buy | Initiate | |
| 2015-03-20 | Maxim Group | Hold | Maintains | |
| 2015-01-29 | Credit Suisse | Buy | Maintains | |
| 2015-01-13 | Citigroup | Buy | Maintains | |
| 2015-01-06 | Barclays | Equal-weight | Initiate | |
| 2015-01-06 | BTIG Research | Buy | Initiate | |
| 2014-10-29 | JMP Securities | Market Outperform | Maintains | |
| 2014-10-28 | JMP Securities | Market Perform | Maintains | |
| 2014-10-13 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2014-10-02 | Guggenheim | Buy | Initiate | |
| 2014-09-17 | Deutsche Bank | Buy | Maintains | |
| 2014-09-16 | Deutsche Bank | Buy | Maintains | |
| 2014-09-08 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2014-07-08 | Oppenheimer | Market Perform | Initiate | |
| 2014-06-25 | UBS | Buy | Maintains | |
| 2014-06-25 | H.C. Wainwright | Buy | Neutral | Downgrade |
| 2014-06-25 | Citigroup | Buy | Maintains | |
| 2014-01-06 | UBS | Neutral | Buy | Upgrade |
| 2014-01-05 | Goldman Sachs | Neutral | Maintains | |
| 2013-10-30 | Summer Street | Buy | Neutral | Downgrade |
| 2013-08-21 | Oppenheimer | Outperform | Initiate | |
| 2013-07-26 | UBS | Buy | Neutral | Downgrade |
| 2013-05-17 | Wunderlich | Buy | Initiate | |
| 2013-05-01 | UBS | Buy | Maintains | |
| 2013-04-22 | Morgan Stanley | Equal-Weight | Maintains | |
| 2013-04-19 | Citigroup | Buy | Maintains | |
| 2013-04-19 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2013-04-19 | Deutsche Bank | Buy | Maintains | |
| 2013-04-19 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2013-04-08 | Canaccord Genuity | Hold | Initiate | |
| 2013-03-19 | JP Morgan | Overweight | Maintains | |
| 2013-01-15 | Lazard | Buy | Neutral | Downgrade |
| 2013-01-11 | Barclays | Overweight | Maintains | |
| 2013-01-02 | Janney Capital | Buy | Initiate | |
| 2012-12-07 | Deutsche Bank | Buy | Maintains | |
| 2012-11-12 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2012-11-02 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2012-11-02 | Credit Suisse | Outperform | Maintains | |
| 2012-10-09 | Deutsche Bank | Buy | Initiate | |
| 2012-10-04 | Argus | Buy | Initiate | |
| 2012-07-31 | Bank of America | Buy | Maintains | |
| 2012-07-31 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-31 | UBS | Buy | Maintains | |
| 2012-07-31 | Citigroup | Buy | Maintains | |
| 2012-07-31 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2012-05-11 | Goldman Sachs | Neutral | Maintains | |
| 2012-04-13 | UBS | Neutral | Maintains | |
| 2012-03-28 | UBS | Neutral | Maintains | |
| 2012-03-14 | Bank oferica | Buy | Maintains | |
| 2024-11-14 | Citigroup | Buy | Initiate | |
| 2024-08-05 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-08-05 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-08-05 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-12-20 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-12-20 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-20 | Needham | Hold | Hold | Reiterate |
| 2024-11-05 | UBS | Buy | Buy | Maintains |
| 2024-11-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-05 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-05 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-11-05 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-12-20 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2024-09-19 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-10-30 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-12-16 | Stifel | Hold | Hold | Maintains |
| 2024-07-19 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2025-02-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-11 | Needham | Hold | Hold | Reiterate |
| 2025-01-24 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-21 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-12-09 | Jefferies | Hold | Buy | Upgrade |
| 2024-08-02 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-10-16 | Scotiabank | Sector Perform | Initiate | |
| 2024-07-31 | Canaccord Genuity | Sell | Sell | Maintains |
| 2025-01-27 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-01-30 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2025-02-20 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-11-06 | Canaccord Genuity | Sell | Sell | Maintains |
| 2024-11-05 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2024-07-22 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-08-05 | Truist Securities | Buy | Buy | Reiterate |
| 2024-08-05 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2024-07-26 | Needham | Hold | Reiterate | |
| 2024-08-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-08-02 | Guggenheim | Buy | Buy | Maintains |
| 2024-10-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-07-23 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-09 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-10-08 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-02-11 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-02-11 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2024-10-17 | UBS | Buy | Buy | Maintains |
| 2025-02-12 | Canaccord Genuity | Sell | Hold | Upgrade |
| 2025-02-11 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-02-11 | Truist Securities | Buy | Buy | Maintains |
| 2025-02-11 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-11 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2024-12-19 | B of A Securities | Buy | Buy | Maintains |
| 2024-10-14 | B of A Securities | Buy | Buy | Maintains |
| 2024-12-23 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2024-12-23 | Truist Securities | Buy | Buy | Maintains |
| 2024-12-23 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-01-31 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2025-01-31 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-01-31 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2025-01-31 | Needham | Hold | Hold | Reiterate |
| 2024-10-01 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-10 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-10-10 | Raymond James | Market Perform | Reiterate | |
| 2025-03-31 | B of A Securities | Buy | Buy | Maintains |
| 2025-04-01 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-06-20 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-05 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2025-08-05 | Truist Securities | Buy | Buy | Maintains |
| 2025-08-05 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-08-05 | BMO Capital | Outperform | Outperform | Maintains |
| 2025-08-05 | UBS | Buy | Buy | Maintains |
| 2025-08-06 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2025-09-03 | Raymond James | Market Perform | Initiate | |
| 2025-05-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-05-06 | Scotiabank | Sector Perform | Sector Perform | Maintains |
| 2025-05-06 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-05-06 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-06 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-05-06 | Needham | Hold | Hold | Reiterate |
| 2025-05-06 | Leerink Partners | Outperform | Market Perform | Downgrade |
| 2025-06-17 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-08-06 | Guggenheim | Buy | Buy | Maintains |
| 2025-08-06 | Canaccord Genuity | Hold | Hold | Maintains |
| 2025-08-05 | Stifel | Hold | Hold | Maintains |
| 2025-08-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-08-05 | HC Wainwright & Co. | Buy | Buy | Maintains |
| 2025-08-05 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2025-06-23 | HC Wainwright & Co. | Buy | Buy | Reiterate |
| 2025-07-14 | JP Morgan | Overweight | Overweight | Maintains |
